| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
| 05/23/2001 | EP1100899A2 Delta-related polypeptides |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100893A1 Nucleic acids encoding proteins involved in sensory transduction |
| 05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100830A2 Heterominibodies |
| 05/23/2001 | EP1100829A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 05/23/2001 | EP1100828A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100825A1 Human mink gene mutations associated with arrhythmia |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100819A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100811A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100810A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100546A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 05/23/2001 | EP1100541A1 Hydrogel for the therapeutic treatment of aneurysms |
| 05/23/2001 | EP1100538A2 Kvlqt1 - a long qt syndrome |
| 05/23/2001 | EP1100529A1 Thymosin beta 4 promotes wound repair |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100515A1 $i(EX VIVO) TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 05/23/2001 | EP1100429A2 Apoptosis proteins |
| 05/23/2001 | EP1100308A1 Copper transporter in ethylene signaling pathway |
| 05/23/2001 | EP0986533A4 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
| 05/23/2001 | EP0932622A4 Vitamin d response element binding protein |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
| 05/23/2001 | DE19955408A1 New invertebrate gamma-aminobutyric acid receptor proteins, useful in screening for potential insecticides, for plant protection or medicine, also related nucleic acid |
| 05/23/2001 | CN1296567A Method and apparatus for detecting conception in animals |
| 05/23/2001 | CN1296016A Extraction of immune globuline G and health care food containing same |
| 05/23/2001 | CN1296015A IgG Fab-BPI fusion protein and DNA sequence thereof |
| 05/23/2001 | CN1296014A Novel human growth arrestin and coding sequence thereof |
| 05/23/2001 | CN1066154C Process for preparing refined vitelline antibody |
| 05/22/2001 | US6235885 Central nervous system disorders |
| 05/22/2001 | US6235884 Heparin binding mitogen with homology to epidermal growth factor (EGF) |
| 05/22/2001 | US6235883 Human monoclonal antibodies to epidermal growth factor receptor |
| 05/22/2001 | US6235880 Polypeptides; hypoglycemic agent |
| 05/22/2001 | US6235879 Apoptosis modulators that interact with the Huntington's disease gene |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235527 Lineage restricted glial precursors from the central nervous system |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235496 Nucleic acid encoding mammalian mu opioid receptor |
| 05/22/2001 | US6235490 Immunoassay of human growth hormone with a molecular weight of about 20,000 |
| 05/22/2001 | US6235485 Heliothis virescens-specific and Helicoverpa zea-specific monoclonal antibodies and insect identification method |
| 05/22/2001 | US6235469 Generation of transcriptional sequences associated with phage envelope protein; incubate and insert nucleotide sequences into expression vector, express gene coded in vector and recover polypeptides |
| 05/22/2001 | US6235290 DNA immunization against chlaymdia infection |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | US6235281 Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6 |
| 05/22/2001 | US6235280 Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
| 05/22/2001 | CA1341235C Modular assembly of antibody genes, antibodies prepared thereby and use |
| 05/17/2001 | WO2001035102A2 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | WO2001034829A2 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 05/17/2001 | WO2001034807A2 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2? |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034797A1 Method of preparing cell fraction containing hemangioblasts |
| 05/17/2001 | WO2001034780A2 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034652A1 Antibodies to suberic acid crosslinkers and methods for using the same |
| 05/17/2001 | WO2001034651A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents |
| 05/17/2001 | WO2001034650A1 Hgf-sf monoclonal antibody combinations |
| 05/17/2001 | WO2001034649A2 Compositions and methods for treating autoimmune diseases and transplant rejections |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034634A2 Tumor suppressor molecules and methods of use |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034195A1 Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
| 05/17/2001 | WO2001034194A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 05/17/2001 | WO2001034183A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 05/17/2001 | WO2001034177A2 Method of treating a viral infection using antagonists of macrophage colony stimulating factor |
| 05/17/2001 | WO2001023893A3 Detection of hla-g |
| 05/17/2001 | WO2001019861A3 Apo-2 receptor antibodies |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001005427B1 Psca: prostate stem cell antigen and uses thereof |